Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALB | P02768 | 2/20 | 0.43 |
| ▸ | PGR | P06401 | 3/20 | 0.42 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.41 |
| ▸ | BRPF1 | P55201 | 4/20 | 0.40 |
| ▸ | BRD1 | O95696 | 3/20 | 0.40 |
| ▸ | BRPF3 | Q9ULD4 | 2/20 | 0.40 |
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
| ▸ | BRD9 | Q9H8M2 | 1/20 | 0.40 |
| ▸ | CSF1R | P07333 | 1/20 | 0.39 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.39 |
| ▸ | NR3C2 | P08235 | 2/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.39 |
| ▸ | TDP2 | O95551 | 2/20 | 0.39 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | GRM4 | Q14833 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6818253 | 0.87 | ROCK2 (0.42) | ALBROCK2RXFP1TRPA1GRM4 | |
| SCHEMBL6814610 | 0.86 | ROCK2 (0.41) | ALBROCK2RXFP1TRPA1ALDH1A1 | |
| SCHEMBL6833349 | 0.84 | PKLR (0.45) | BRD4ALDH1A1 | |
| SCHEMBL7071019 | 0.83 | ALDH1A1 (0.44) | ALBNR3C2ALDH1A1 | |
| SCHEMBL6817988 | 0.83 | NAMPT (0.43) | ALBPGRROCK2BRD4ALDH1A1 | |
| SCHEMBL6833234 | 0.83 | KDM4C (0.43) | ALBROCK2RXFP1ALDH1A1GRM4 | |
| SCHEMBL6818878 | 0.82 | ALB (0.56) | ALBTRPA1GRM4 | |
| SCHEMBL6835702 | 0.82 | MAPT (0.47) | ALBALDH1A1 | |
| SCHEMBL6835753 | 0.81 | ROCK2 (0.40) | ALBROCK2ALDH1A1GRM4 | |
| SCHEMBL6833692 | 0.81 | IMPDH2 (0.49) | ALBROCK2TRPA1GRM4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | PHARMACIA & UPJOHN COMPANY | 2004-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040110802-A1 | Antibacterial benzoic acid derivatives | GABRD, GABBR1, GABRA1 | ALB 1417/4885PGR 3560/4885ROCK2 4866/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.